Published in Stroke on October 01, 2000
A review of carotid atherosclerosis and vascular cognitive decline: a new understanding of the keys to symptomology. Neurosurgery (2010) 1.04
Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol (2011) 1.03
Cerebral collateral circulation in carotid artery disease. Curr Cardiol Rev (2009) 0.93
All's well that transcribes well: non-coding RNAs and post-stroke brain damage. Neurochem Int (2013) 0.88
Bilateral carotid artery occlusion with transient or moderately disabling ischaemic stroke: clinical features and long-term outcome. J Neurol (2009) 0.83
Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke (2001) 0.80
High-grade symptomatic and asymptomatic carotid stenosis in the very elderly. A challenge for proponents of carotid angioplasty and stenting. BMC Cardiovasc Disord (2006) 0.78
Carotid endarterectomy with contralateral carotid occlusion: is shunting necessary? Int J Angiol (2012) 0.77
Does a contralateral carotid occlusion adversely impact carotid artery stenting outcomes? Ann Vasc Surg (2011) 0.76
Characteristics that define high risk in carotid endarterectomy from the Vascular Study Group of New England. J Vasc Surg (2015) 0.75
Carotid artery stenting of a contralateral occlusion and in-hospital outcomes: results from the CARE (Carotid Artery Revascularization and Endarterectomy) registry. JACC Cardiovasc Interv (2013) 0.75
Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1999) 7.93
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology (2001) 4.78
Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes (1996) 4.20
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol (1995) 3.24
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke (1995) 2.86
Medical compared with surgical treatment of asymptomatic carotid artery stenosis. Ann Intern Med (1995) 2.72
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Int J Stroke (2010) 2.71
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke (1996) 2.51
The global burden of disease study: implications for neurology. Arch Neurol (2000) 2.44
Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study. Stroke (1991) 2.42
Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care (1999) 2.17
Predictive value of induction of psychogenic seizures by suggestion. Ann Neurol (1994) 2.15
Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation (1990) 1.99
Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol (2000) 1.93
Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. J Clin Microbiol (2001) 1.84
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Diabetes Care (1998) 1.83
Evaluation of social status as a contributing factor to the stroke belt region of the United States. Stroke (1997) 1.81
Who asks for vasectomy reversal and why? Br Med J (Clin Res Ed) (1982) 1.76
Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene (2010) 1.72
Hypertension and subclinical carotid artery atherosclerosis in blacks and whites. The Atherosclerosis Risk in Communities Study. ARIC Investigators. Arch Intern Med (1996) 1.71
Retention of water-borne bacteria by membrane filters. Part I: Bacterial challenge tests on 0.2 and 0.22 micron rated filters. PDA J Pharm Sci Technol (2001) 1.69
Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987-1994. Am Heart J (2000) 1.69
Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke (1998) 1.67
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1998) 1.65
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int (2000) 1.62
Transient global amnesia. Ann Neurol (1980) 1.61
Is the stroke belt disappearing? An analysis of racial, temporal, and age effects. Stroke (1995) 1.60
Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology (2006) 1.57
Comparison of mannitol regimens in patients with severe head injury undergoing intracranial monitoring. J Neurosurg (1986) 1.54
Decline in US stroke mortality: an analysis of temporal patterns by sex, race, and geographic region. Stroke (2001) 1.51
Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology (2011) 1.49
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48
Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol (1999) 1.48
Quality-based medicine. Arch Neurol (1997) 1.47
Physical activity and ischemic stroke risk. The atherosclerosis risk in communities study. Stroke (1999) 1.46
Association of higher diastolic blood pressure levels with cognitive impairment. Neurology (2009) 1.43
Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke (1996) 1.42
Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes (1997) 1.42
Presidential disability and the twenty-fifth amendment. JAMA (1994) 1.42
Some legal issues relating to passive smoking at the workplace. Br J Addict (1990) 1.41
Transient ischemic attacks due to atherosclerosis. A prospective study of 160 patients. Arch Neurol (1975) 1.40
Ethnic disparities in stroke: the scope of the problem. Ethn Dis (2001) 1.40
Correlation of carotid bruits and carotid atherosclerosis detected by B-mode real-time ultrasonography. Stroke (1989) 1.39
Sickness dismissals--a management perspective. Occup Health (Lond) (1991) 1.39
Amyloidosis of the orbit and adnexae. Surv Ophthalmol (1975) 1.38
Multi-disciplinary approach to cranial base tumors. J S C Med Assoc (1994) 1.37
Relationship of periodontal disease and edentulism to stroke/TIA. J Dent Res (2003) 1.32
Transcription activation at the Escherichia coli melAB promoter: the role of MelR and the cyclic AMP receptor protein. Mol Microbiol (2000) 1.31
Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke (1997) 1.25
The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prev Med (1995) 1.22
Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology (2001) 1.21
Tobacco farmers and diversification: opportunities and barriers. Tob Control (1996) 1.21
The transient global amnesia-migraine connection. Arch Neurol (1984) 1.21
The effect of radiation on carotid arteries. A review article. Arch Neurol (1989) 1.20
Use of intrauterine devices in nulliparous women. Lancet (1972) 1.17
Early rheumatoid arthritis in African-Americans: the CLEAR Registry. Clin Exp Rheumatol (2004) 1.17
Effects of change of head, limb and body position on cephalic circulation. N Engl J Med (1968) 1.14
Kinks, coils, and carotids: a review. Stroke (1976) 1.14
Role of social class in excess black stroke mortality. Stroke (1995) 1.13
Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb (1991) 1.12
Measurement variability of carotid atherosclerosis: real-time (B-mode) ultrasonography and angiography. Stroke (1988) 1.12
Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. The ARIC Study, 1987-1989. Am J Epidemiol (1996) 1.10
Retention of water-borne bacteria by membrane filters. Part II: Scanning electron microscopy (SEM) and fatty acid methyl ester (FAME) characterization of bacterial species recovered downstream of 0.2/0.22 micron rated filters. PDA J Pharm Sci Technol (2001) 1.10
Precapillary arteriovenous anastomoses. "Thoroughfare channels" in the brain. Arch Neurol (1967) 1.08
Regarding "Statement regarding carotid angioplasty and stenting". J Vasc Surg (1997) 1.07
Retention of water-borne bacteria by membrane filters. Part III: Bacterial challenge tests on 0.1 micron rated filters. PDA J Pharm Sci Technol (2001) 1.06
Factors influencing the survival of 451 transient ischemic attack patients. Stroke (1987) 1.05
Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis (1992) 1.05
Method for qualifying microbial removal performance of 0.1 micron rated filters. Part II: preliminary characterization of Hydrogenophaga (formerly Pseudomonas) pseudoflava for use as a standard challenge organism to qualify 0.1 micron rated filters. PDA J Pharm Sci Technol (2001) 1.04
Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol (1982) 1.03
Surgical results: a justification of the surgeon selection process for the ACAS trial. The ACAS Investigators. J Vasc Surg (1996) 1.03
Motivation for vasectomy. Lancet (1978) 1.03
Method for qualifying microbial removal performance of 0.1 micron rated filters. Part I: characterization of water isolates for potential use as standard challenge organisms to qualify 0.1 micron rated filters. PDA J Pharm Sci Technol (2001) 1.02
Sickle-cell trait: benign or malignant? Ann Intern Med (1972) 1.02
Regulation of amylase gene expression in diabetic mice is mediated by a cis-acting upstream element close to the pancreas-specific enhancer. Genes Dev (1990) 1.02
Carotid and vertebrobasilar transient ischemic attacks: clinical and angiographic correlation. Neurology (1979) 1.02
Communication between older adults and their physicians about urinary incontinence. J Gerontol A Biol Sci Med Sci (1999) 1.00
Method for qualifying microbial removal performance of 0.1 micron rated filters. Part III: bacterial challenge tests on 0.2/0.22 and 0.1 micron rated filter cartridges with Hydrogenophaga (formerly Pseudomonas) pseudoflava. PDA J Pharm Sci Technol (2001) 1.00
Validation of the ACAS TIA/stroke algorithm. Neurology (1997) 1.00
Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis (2008) 0.99
Declining morbidity and mortality of carotid endarterectomy. The Wake Forest University Medical Center experience. Stroke (1987) 0.99
Recurrent carotid stenosis : results of the asymptomatic carotid atherosclerosis study. Stroke (1998) 0.99
Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke (1992) 0.98